ARTICLE | Company News
Telesta, Ipsen deal
November 23, 2015 8:00 AM UTC
Telesta granted Ipsen exclusive, worldwide rights, excluding North America, South Africa, South Korea and Japan, to develop and commercialize MCNA to treat high risk non-muscle invasive bladder cance...